These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 26048626)

  • 21. Novel mutation identified in severe early-onset tumor necrosis factor receptor-associated periodic syndrome: a case report.
    Radhakrishna SM; Grimm A; Broderick L
    BMC Pediatr; 2017 Apr; 17(1):108. PubMed ID: 28427379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in the diagnosis and treatment of tumor necrosis factor receptor-associated periodic syndrome.
    Aguado-Gil L; Irarrazaval-Armendáriz I; Pretel-Irazabal M
    Actas Dermosifiliogr; 2013 Sep; 104(7):617-22. PubMed ID: 23891452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Progress in classification and treatment for TNF receptor-associated periodic syndrome].
    Tsukamoto H; Ueda N; Horiuchi T
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(5):361-8. PubMed ID: 22041423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome.
    de Koning HD; Schalkwijk J; van der Ven-Jongekrijg J; Stoffels M; van der Meer JW; Simon A
    Ann Rheum Dis; 2013 Oct; 72(10):1634-8. PubMed ID: 23087179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel TNFRSF1A gene mutation in a patient with tumor necrosis factor receptor-associated periodic syndrome.
    Khabazi A; Maralani M; Andalib S; Sakhinia E
    Hematol Oncol Stem Cell Ther; 2018 Sep; 11(3):175-177. PubMed ID: 27793577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On-demand treatment with anakinra: a treatment option for selected TRAPS patients.
    Grimwood C; Despert V; Jeru I; Hentgen V
    Rheumatology (Oxford); 2015 Sep; 54(9):1749-51. PubMed ID: 26078218
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy and safety of canakinumab in cryopyrin-associated periodic syndromes: results from a Spanish cohort.
    Anton J; Calvo I; Fernández-Martin J; Gamir ML; Merino R; Jimenez-Treviño S; Sevilla B; Cabades F; Bou R; Arostegui JI
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S67-71. PubMed ID: 26243511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumour necrosis factor receptor-1 associated periodic syndrome (TRAPS)-related AA amyloidosis: a national case series and systematic review.
    Delaleu J; Deshayes S; Rodrigues F; Savey L; Rivière E; Silva NM; Aouba A; Amselem S; Rabant M; Grateau G; Giurgea I; Georgin-Lavialle S
    Rheumatology (Oxford); 2021 Dec; 60(12):5775-5784. PubMed ID: 33715002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases.
    Bettiol A; Lopalco G; Emmi G; Cantarini L; Urban ML; Vitale A; Denora N; Lopalco A; Cutrignelli A; Lopedota A; Venerito V; Fornaro M; Vannacci A; Rigante D; Cimaz R; Iannone F
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30999610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel TNFRSF1 gene mutation in a Turkish family: a report of three cases.
    Cosan F; Yazici A; Yılmazer B; Gul A; Ustek D; Cefle A
    Clin Rheumatol; 2013 Mar; 32 Suppl 1():S83-5. PubMed ID: 20532935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophage activation syndrome as the initial manifestation of tumour necrosis factor receptor 1-associated periodic syndrome (TRAPS).
    Horneff G; Rhouma A; Weber C; Lohse P
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):99-102. PubMed ID: 24064022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different presentations in patients with tumor necrosis factor receptor-associated periodic syndrome mutations: report of two cases.
    Celebi-Tayfur A; Bilginer Y; Finetti M; Gattorno M; Ozen S
    Turk J Pediatr; 2013; 55(1):78-81. PubMed ID: 23692837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and genetic features of Chinese adult patients with tumour necrosis factor receptor-associated periodic fever syndrome.
    Zhao M; Luo Y; Wu D; Yang Y; Sun Y; Wang R; Shen M
    Rheumatology (Oxford); 2020 Aug; 59(8):1969-1974. PubMed ID: 31774538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Digenic MEFV/TNFRSF1A autoinflammatory syndrome with relapsing aseptic neutrophilic meningitis and chronic myelitis.
    Murarasu A; Dodé C; Sarrabay G; Klein I; Papo T; Sacré K
    Clin Exp Rheumatol; 2017; 35 Suppl 108(6):128-129. PubMed ID: 28134085
    [No Abstract]   [Full Text] [Related]  

  • 35. Circulating intercellular adhesion molecule 1 (sICAM-1) in tumour necrosis factor receptor-associated periodic syndrome (TRAPS).
    Cantarini L; Pucino V; Vitale A; Lucherini OM; Obici L; Matarese G
    Clin Exp Rheumatol; 2017; 35 Suppl 104(2):13-14. PubMed ID: 28375838
    [No Abstract]   [Full Text] [Related]  

  • 36. Canakinumab efficacy in refractory adult-onset PFAPA syndrome.
    Lopalco G; Rigante D; Vitale A; Caso F; Iannone F; Cantarini L
    Int J Rheum Dis; 2017 Aug; 20(8):1050-1051. PubMed ID: 26200174
    [No Abstract]   [Full Text] [Related]  

  • 37. Multigene sequencing reveals heterogeneity of NLRP12-related autoinflammatory disorders.
    Kostik MM; Suspitsin EN; Guseva MN; Levina AS; Kazantseva AY; Sokolenko AP; Imyanitov EN
    Rheumatol Int; 2018 May; 38(5):887-893. PubMed ID: 29500522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Canakinumab reverses overexpression of inflammatory response genes in tumour necrosis factor receptor-associated periodic syndrome.
    Torene R; Nirmala N; Obici L; Cattalini M; Tormey V; Caorsi R; Starck-Schwertz S; Letzkus M; Hartmann N; Abrams K; Lachmann H; Gattorno M
    Ann Rheum Dis; 2017 Jan; 76(1):303-309. PubMed ID: 27474763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Setting up TRAPS.
    Pettersson T; Kantonen J; Matikainen S; Repo H
    Ann Med; 2012 Mar; 44(2):109-18. PubMed ID: 21284532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent migratory angioedema as cutaneous manifestation in a familiar case of TRAPS: dramatic response to Anakinra.
    Cattalini M; Meini A; Monari P; Gualdi G; Arisi M; Pelucchi F; Bolognini S; Gattorno M; Calzavara-Pinton PG; Plebani A
    Dermatol Online J; 2013 Nov; 19(11):20405. PubMed ID: 24314780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.